| Record ID | marc_records_scriblio_net/part27.dat:151587222:1378 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part27.dat:151587222:1378?format=raw |
LEADER: 01378cam 2200289 a 4500
001 98161438
003 DLC
005 20021216160101.0
008 980617s1997 nju s000 0 eng d
010 $a 98161438
035 $a(OCoLC)38734063
040 $aNj$cNj$dDLC
042 $alccopycat
043 $an-us-nj
050 00 $aKFN1811.4$b.P64 1997a
110 1 $aNew Jersey.$bLegislature.$bGeneral Assembly.$bPolicy and Regulatory Oversight Committee.
245 10 $aPublic hearing before Assembly Policy and Regulatory Oversight Committee and Assembly Health Committee :$btestimony on cost-benefit, accessibility, insurance coverage of clinical trials, and the latest developments in pediatric and breast cancer research /$chearing recorded and transcribed by the Office of Legislative Services, Public Information Office, Hearing Unit.
260 $aTrenton, N.J. :$bThe Unit,$c[1997]
300 $a160, 78 p. ;$c28 cm.
500 $aCover title.
500 $aHearing held Sept. 25, 1997 in Hackensack, N.J.
650 0 $aInsurance, Cancer$xGovernment policy$zNew Jersey.
650 0 $aInsurance, Health$xGovernment policy$zNew Jersey.
650 0 $aClinical trials$zNew Jersey$xFinance.
650 0 $aCancer$xResearch$zNew Jersey.
650 0 $aCancer$xTreatment$zNew Jersey$xCost effectiveness.
710 1 $aNew Jersey.$bLegislature.$bGeneral Assembly.$bHealth Committee.